BioNTech SE at JPMorgan Healthcare Conference Transcript
Great. Good morning or good afternoon from the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce BioNTech and CEO, Ugur Sahin, who really needs no introduction. (Operator Instructions).
Thanks so much for joining us today. Let me turn things over to you for an update.
So thank you, Cory. Thank you for the introduction and invitation to present at the conference. Good morning, good afternoon, and thank you to everyone listening to our presentation today. In my presentation, I'm going to start with a recap of 2021 and the historic impact BioNTech had on [June half]. I will then highlight our multi-platform strategy and diversified pipeline. And I will close with a review of our outlook for the coming years. After my presentation, I will be joined by other members of our management team for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
